Tempus AI Sees Unusually Large Options Volume (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) was the target of some unusual options trading on Wednesday. Stock traders purchased 51,813 call options on the stock. This is an increase of approximately 264% compared to the typical volume of 14,225 call options.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company’s stock, valued at $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Andrew Polovin sold 51,504 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the sale, the executive vice president now directly owns 246,085 shares in the company, valued at approximately $10,431,543.15. This represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 2,037,702 shares of company stock valued at $89,449,651.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. ARK Investment Management LLC boosted its position in shares of Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after acquiring an additional 3,141,487 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Tempus AI in the fourth quarter valued at $1,615,000. IFP Advisors Inc acquired a new position in Tempus AI during the fourth quarter worth about $76,000. First Horizon Advisors Inc. increased its position in shares of Tempus AI by 207.9% in the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock valued at $55,000 after buying an additional 1,108 shares in the last quarter. Finally, Sigma Planning Corp increased its position in Tempus AI by 43.9% during the fourth quarter. Sigma Planning Corp now owns 33,638 shares of the company’s stock worth $1,136,000 after buying an additional 10,269 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on TEM shares. Piper Sandler reiterated a “neutral” rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective for the company. Guggenheim assumed coverage on shares of Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 target price for the company. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and an average price target of $56.36.

Tempus AI Stock Performance

TEM stock opened at $61.85 on Wednesday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business’s fifty day moving average price is $44.20 and its 200 day moving average price is $48.58. Tempus AI has a 12-month low of $22.89 and a 12-month high of $79.49.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.